These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30995800)

  • 1. Systemic Sclerosis is Linked to Psoriasis and May Impact on Patients' Survival: A Large Cohort Study.
    Watad A; Bragazzi NL; McGonagle D; Damiani G; Comaneshter D; Cohen A; Amital H
    J Clin Med; 2019 Apr; 8(4):. PubMed ID: 30995800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody status in systemic sclerosis patients defines both cancer risk and survival with ANA negativity in cases with concomitant cancer having a worse survival.
    Watad A; McGonagle D; Bragazzi NL; Tiosano S; Comaneshter D; Shoenfeld Y; Cohen AD; Amital H
    Oncoimmunology; 2019; 8(6):e1588084. PubMed ID: 31069155
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic sclerosis patients are at higher risk of hyperthyroidism and have a worse survival than those without hyperthyroidism: A nationwide population-based cohort study.
    Akuka A; Watad A; Comaneshter D; Cohen AD; Amital H; Bragazzi NL
    Eur J Clin Invest; 2019 Dec; 49(12):e13177. PubMed ID: 31633804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival.
    Wodkowski M; Hudson M; Proudman S; Walker J; Stevens W; Nikpour M; Assassi S; Mayes MD; Wang M; Baron M; Fritzler MJ; ; ;
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S131-5. PubMed ID: 26315678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic sclerosis is an independent risk factor for ischemic heart disease, especially in patients carrying certain antiphospholipid antibodies: A large cross-sectional study.
    Watad A; McGonagle D; Bragazzi NL; Damiani G; Comaneshter D; Lidar M; Cohen AD; Amital H
    Eur J Intern Med; 2020 Nov; 81():44-49. PubMed ID: 32620499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and Survival of Systemic Sclerosis-Systemic Lupus Erythematosus Overlap Syndrome.
    Alharbi S; Ahmad Z; Bookman AA; Touma Z; Sanchez-Guerrero J; Mitsakakis N; Johnson SR
    J Rheumatol; 2018 Oct; 45(10):1406-1410. PubMed ID: 30008448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China.
    Hu S; Hou Y; Wang Q; Li M; Xu D; Zeng X
    Arthritis Res Ther; 2018 Oct; 20(1):235. PubMed ID: 30348207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's Disease in Systemic Sclerosis Patients: A Nationwide Population-Based Cohort Study.
    Watad A; Bragazzi NL; Tiosano S; Yavne Y; Comaneshter D; Cohen AD; Amital H
    J Alzheimers Dis; 2018; 65(1):117-124. PubMed ID: 30040736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic sclerosis patients with negative antinuclear antibodies have distinctive clinical manifestations: a multicenter CRDC cohort in China.
    Hui M; Wang X; Zhou J; Zhang L; Duan X; Li M; Wang Q; Zhao J; Hou Y; Xu D; Zeng X
    Z Rheumatol; 2024 Feb; 83(Suppl 1):160-166. PubMed ID: 35852599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinuclear antibody-negative systemic sclerosis.
    Salazar GA; Assassi S; Wigley F; Hummers L; Varga J; Hinchcliff M; Khanna D; Schiopu E; Phillips K; Furst DE; Steen V; Baron M; Hudson M; Taillefer SS; Pope J; Jones N; Docherty P; Khalidi NA; Robinson D; Simms RW; Silver RM; Frech TM; Fessler BJ; Molitor JA; Fritzler MJ; Segal BM; Al-Kassab F; Perry M; Yang J; Zamanian S; Reveille JD; Arnett FC; Pedroza C; Mayes MD
    Semin Arthritis Rheum; 2015 Jun; 44(6):680-6. PubMed ID: 25578738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis.
    Minier T; Guiducci S; Bellando-Randone S; Bruni C; Lepri G; Czirják L; Distler O; Walker UA; Fransen J; Allanore Y; Denton C; Cutolo M; Tyndall A; Müller-Ladner U; Matucci-Cerinic M; ;
    Ann Rheum Dis; 2014 Dec; 73(12):2087-93. PubMed ID: 23940211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study.
    Li X; Qian YQ; Liu N; Mu R; Zuo Y; Wang GC; Jia Y; Li ZG
    Clin Rheumatol; 2018 Nov; 37(11):3051-3056. PubMed ID: 30225558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran.
    Poormoghim H; Andalib E; Jalali A; Ghaderi A; Ghorbannia A; Mojtabavi N
    Rheumatol Int; 2016 Jul; 36(7):925-34. PubMed ID: 27061806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-PM-Scl antibody in patients with systemic sclerosis.
    Koschik RW; Fertig N; Lucas MR; Domsic RT; Medsger TA
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S12-6. PubMed ID: 22261302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gout Augments the Risk of Cardiovascular Disease in Patients With Psoriasis: A Population-Based Cohort Study.
    Chen Z; Xu Y; Chen M; Cui R; Wang YH; Dai SM; Wei JC
    Front Immunol; 2021; 12():703119. PubMed ID: 34335617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic sclerosis and the risk of tuberculosis.
    Ou SM; Fan WC; Chou KT; Yeh CM; Su VY; Hung MH; Chang YS; Lee YJ; Chen YT; Chao PW; Yang WC; Chen TJ; Wang WS; Tsao HM; Chen LF; Lee FY; Liu CJ
    J Rheumatol; 2014 Aug; 41(8):1662-9. PubMed ID: 25028380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis.
    Pauling JD; Salazar G; Lu H; Betteridge ZE; Assassi S; Mayes MD; McHugh NJ
    Rheumatology (Oxford); 2018 Apr; 57(4):712-717. PubMed ID: 29294089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis.
    Simeon CP; Armadans L; Fonollosa V; Vilardell M; Candell J; Tolosa C; Mearin F; Rodrigo MJ; Solans R; Lima J; Sampol G
    Ann Rheum Dis; 1997 Dec; 56(12):723-8. PubMed ID: 9496151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of male sex on survival in systemic sclerosis.
    Hussein H; Lee P; Chau C; Johnson SR
    J Rheumatol; 2014 Nov; 41(11):2193-200. PubMed ID: 25274896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malnutrition is an independent risk factor for mortality in Mexican patients with systemic sclerosis: a cohort study.
    Cruz-Domínguez MP; García-Collinot G; Saavedra MA; Montes-Cortes DH; Morales-Aguilar R; Carranza-Muleiro RA; Vera-Lastra OL; Jara LJ
    Rheumatol Int; 2017 Jul; 37(7):1101-1109. PubMed ID: 28555363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.